JP2009541309A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541309A5
JP2009541309A5 JP2009516443A JP2009516443A JP2009541309A5 JP 2009541309 A5 JP2009541309 A5 JP 2009541309A5 JP 2009516443 A JP2009516443 A JP 2009516443A JP 2009516443 A JP2009516443 A JP 2009516443A JP 2009541309 A5 JP2009541309 A5 JP 2009541309A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoroalkyl
nhc
methoxy
benzoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009516443A
Other languages
English (en)
Japanese (ja)
Other versions
JP5548842B2 (ja
JP2009541309A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2007/000591 external-priority patent/WO2007149030A1/en
Publication of JP2009541309A publication Critical patent/JP2009541309A/ja
Publication of JP2009541309A5 publication Critical patent/JP2009541309A5/ja
Application granted granted Critical
Publication of JP5548842B2 publication Critical patent/JP5548842B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009516443A 2006-06-19 2007-06-18 新規なヘテロアリール置換ベンゾオキサゾール Expired - Fee Related JP5548842B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81493606P 2006-06-19 2006-06-19
US60/814,936 2006-06-19
PCT/SE2007/000591 WO2007149030A1 (en) 2006-06-19 2007-06-18 Novel heteroaryl substituted benzoxazoles

Publications (3)

Publication Number Publication Date
JP2009541309A JP2009541309A (ja) 2009-11-26
JP2009541309A5 true JP2009541309A5 (enExample) 2010-08-05
JP5548842B2 JP5548842B2 (ja) 2014-07-16

Family

ID=38833677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516443A Expired - Fee Related JP5548842B2 (ja) 2006-06-19 2007-06-18 新規なヘテロアリール置換ベンゾオキサゾール

Country Status (16)

Country Link
US (1) US7670591B2 (enExample)
EP (1) EP2035418A1 (enExample)
JP (1) JP5548842B2 (enExample)
KR (1) KR20090021224A (enExample)
CN (1) CN101506201B (enExample)
AR (1) AR061515A1 (enExample)
AU (1) AU2007261786A1 (enExample)
CA (1) CA2655084A1 (enExample)
CL (1) CL2007001784A1 (enExample)
IL (1) IL195669A0 (enExample)
MX (1) MX2008015718A (enExample)
NO (1) NO20090201L (enExample)
TW (1) TW200813035A (enExample)
UY (1) UY30419A1 (enExample)
WO (1) WO2007149030A1 (enExample)
ZA (1) ZA200810163B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200736252A (en) * 2006-01-27 2007-10-01 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
TW200901998A (en) 2007-03-06 2009-01-16 Astrazeneca Ab Novel 2-heteroaryl substituted benzothiophenes and benzofuranes
AU2009260519A1 (en) * 2008-05-30 2009-12-23 Merck Sharp & Dohme Corp. Novel substituted azabenzoxazoles
JP2012507534A (ja) * 2008-10-31 2012-03-29 メルク・シャープ・エンド・ドーム・コーポレイション 新規置換アザベンゾオキサゾール類
AU2011293612B2 (en) * 2010-08-23 2015-11-26 Syntrix Biosystems Inc. Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
US20140031547A1 (en) * 2010-12-14 2014-01-30 Electrophoretics Limited CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
JPWO2014132919A1 (ja) * 2013-02-28 2017-02-02 国立大学法人京都大学 診断用組成物
KR101499329B1 (ko) * 2013-06-17 2015-03-06 주식회사 대웅제약 (2-(3,4-다이메톡시페닐)-5-(3-메톡시프로필)벤조퓨란)의결정형 및 이의 제조방법
JP6149684B2 (ja) * 2013-10-21 2017-06-21 ブラザー工業株式会社 携帯端末、画像処理装置、及びプログラム
WO2015112048A1 (en) * 2014-01-24 2015-07-30 Huawei Technologies Co., Ltd. Method and device for cross-polarization interference suppression
CN104059028B (zh) * 2014-06-06 2020-10-16 北京智博高科生物技术有限公司 与Aβ斑块具有亲和力的含手性侧链取代的氟代2-芳基苯并杂环化合物、其制备方法及应用
KR101709731B1 (ko) * 2015-05-22 2017-02-23 한국과학기술연구원 벤조옥사졸 또는 벤조티아졸 화합물, 그의 제조, 및 용도
US10324943B2 (en) * 2015-08-10 2019-06-18 Business Objects Software, Ltd. Auto-monitoring and adjustment of dynamic data visualizations
CN107949383B (zh) * 2015-08-18 2022-08-23 加利福尼亚大学董事会 用于成像的含氮氧化合物的淀粉样蛋白结合剂
KR101812424B1 (ko) * 2016-12-28 2017-12-27 충북대학교 산학협력단 2-(2-아미노-5-(1-(피퍼리딘-4-일)-1H-피라졸-3-일)피리딘-3-일)벤조[d]옥사졸-6-올 및 이를 유효성분으로 포함하는 치매의 예방 및 치료용 조성물
AU2021214076A1 (en) * 2020-01-28 2022-08-04 Protego Biopharma, Inc. Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
GB8305245D0 (en) 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
JPS6394248A (ja) * 1986-10-08 1988-04-25 Canon Inc 電子写真感光体
CA2034309C (en) * 1990-01-22 1997-04-01 Takashi Iwaki Mesomorphic compound, liquid crystal composition containing same, liquid crystal device using same and display apparatus
JPH09507071A (ja) 1993-12-21 1997-07-15 イーライ・リリー・アンド・カンパニー アミロイド原性ペプチドに関連した状態を治療又は予防する方法
US5518713A (en) * 1995-02-13 1996-05-21 3V Inc. Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
JPH11116476A (ja) 1997-10-16 1999-04-27 Sankyo Co Ltd 縮合複素環化合物
DK1334091T3 (da) 2000-08-24 2012-10-15 Univ Pittsburgh Thioflavinderivater og deres anvendelse til diagnose og terapi af Alzheimer's sygdom
JP2004524289A (ja) 2000-12-22 2004-08-12 アストラゼネカ・アクチエボラーグ 治療化合物
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
ES2274973T3 (es) 2001-04-23 2007-06-01 The Trustees Of The University Of Pennsylvania Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas.
AU2002349477A1 (en) * 2001-11-26 2003-06-10 Takeda Chemical Industries, Ltd. Bicyclic derivative, process for producing the same, and use
GB0130305D0 (en) 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
AU2003242233A1 (en) 2002-06-12 2003-12-31 Bf Research Institute, Inc. Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation
TW200401194A (en) 2002-07-11 2004-01-16 Advanced Micro Devices Inc Method and apparatus for determining a processor state without interrupting processor operation
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
JP2004250411A (ja) 2003-02-21 2004-09-09 Bf Kenkyusho:Kk アミロイドβ蓄積性疾患の診断プローブおよび治療用化合物
CA2438032C (en) 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
EP1612204A4 (en) 2003-03-31 2007-04-11 Daiichi Seiyaku Co HYDRAZONE DERIVATIVE
DE602004016328D1 (de) 2003-05-13 2008-10-16 Hoffmann La Roche 2-imidazo-benzothiazole als adenosin-rezeptor liganden
ES2427963T3 (es) 2004-07-02 2013-11-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Uso de derivados de tioflavina radiomarcados en formación de imágenes de amiloide para evaluación de las terapias antiamiloide
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1893576A4 (en) 2005-05-27 2010-03-17 Univ Kingston TREATMENT OF PROTEIN DISORDERING
WO2007033080A2 (en) 2005-09-12 2007-03-22 Emory University Alzheimer's disease imaging agents
EP1937260A2 (en) 2005-09-16 2008-07-02 University of Pittsburgh In-vivo and in-vitro method for detecting amyloid deposits having at least one amyloidogenic protein
EP1945622B1 (en) 2005-10-11 2011-12-28 University of Pittsburgh - Of the Commonwealth System of Higher Education Isotopically-labeled benzofuran compounds as imagingagents for amyloidogenic proteins
EP1956013B1 (en) 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
TW200736252A (en) 2006-01-27 2007-10-01 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
US8518980B2 (en) * 2006-02-10 2013-08-27 Summit Corporation Plc Treatment of Duchenne muscular dystrophy
US7700616B2 (en) * 2006-05-08 2010-04-20 Molecular Neuroimaging, Llc. Compounds and amyloid probes thereof for therapeutic and imaging uses
EP2125800A1 (en) 2007-01-22 2009-12-02 AstraZeneca AB Novel heteroaryl substituted imidazo ý1,2 -a¨pyridine derivatives

Similar Documents

Publication Publication Date Title
RU2008130965A (ru) Новые гетероарил-замещенные бензотиазолы
JP2009528271A5 (enExample)
US7670591B2 (en) Heteroaryl substituted benzoxazoles
JP2010520276A5 (enExample)
RU2008110949A (ru) Соединения и композиции-иммуносупрессанты
RU2008150631A (ru) Композиция для диагностики амилоид-связанного заболевания
JP4751957B2 (ja) アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬
JP2012510467A5 (enExample)
HRP20211778T1 (hr) Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
ME00586B (me) Fungicidni azociklični amidi
JP2014521662A5 (enExample)
JP2009531322A5 (enExample)
JP2017528520A5 (enExample)
RU2006107563A (ru) Зонды для заболеваний с накоплением амилоида, красители для амилоида, лекарства для лечения и профилактики заболеваний с накоплением амилоида, зонды для диагностики нейрофибриллярных клубков и красители для нейрофибриллярных клубков
JP2006522035A5 (enExample)
JP2018536671A5 (enExample)
JP2018524338A5 (enExample)
JP2009535334A5 (enExample)
JP2018531897A5 (enExample)
RU2018110055A (ru) Зонды визуализации белка гентингтина
JP2009501745A5 (enExample)
RU2009133256A (ru) Новые 2-гетероарил-замещенные индолы 695
JP4738443B2 (ja) アミロイドの凝集及び/又は沈着に起因する疾患のイメージング薬及び治療薬
JP2008509892A5 (ja) 高脂血症及び糖尿病の治療のためのpparリガンド(ペルオキシソーム増殖剤応答性受容体)として使用されるn−(フェニル−オキサゾール−4−イルメトキシメチル)−シクロヘキシル−スクシンアミド誘導体及び関連する化合物
JP2009519227A5 (enExample)